Effects of Combined Rectus Sheath and Ilioinguinal Nerve Block on Opioid Consumption in HALDN
1 other identifier
interventional
66
1 country
1
Brief Summary
The goal of this double-blind randomized control clinical trial is to investigate the effectiveness of regional anaesthesia blocks (rectus sheath block and ilioinguinal nerve block) on pain management in patients undergoing hand assisted laparoscopic donor nephrectomy surgery. The main question it aims to answer is: Does combined rectus sheath block and ilioinguinal nerve block lower the amount of postoperative opioid consumption? Does reduced postoperative opioid consumption reduce the incidence of potential opioid related side effects? Does the application of nerve block affect length of hospital stay? Researchers will compare patients who had nerve blocks with regional anaesthesia to a placebo group to see if total postoperative opioid consumption. Participants will be randomly divided in two. Regional anaesthesia with local anaesthesia or a placebo will be performed. Patients will be followed 24 hours postoperatively to measure total opioid consumption. Possible side effects, complications and length of hospital stay will be noted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2025
CompletedStudy Start
First participant enrolled
March 30, 2025
CompletedFirst Posted
Study publicly available on registry
April 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2025
CompletedAugust 28, 2025
January 1, 2025
4 months
January 30, 2025
August 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary Outcome
Determination of the total amount of narcotic painkillers used during this period.
24 hours post-surgery
Secondary Outcomes (5)
Secondary Outcome
24 hours post-surgery
Secondary Outcome
24 hours post-surgery
Secondary Outcome
through patient discharge postoperative, an average of 5 days postoperatively
Secondary Outcome
1,3,6,12 hours post-surgery
Secondary Outcome
1,3,6,12 hours post-surgery
Study Arms (2)
Group Sham
SHAM COMPARATORAfter the induction of general anaesthesia, the rectus sheath block and ilioinguinal nerve block will be performed to patients with a solution containing only physiological saline.
Group Block
ACTIVE COMPARATORAfter the induction of general anaesthesia, the rectus sheath block and ilioinguinal nerve block will be performed to patients with a solution containing 0.25% bupivacaine.
Interventions
Rectus sheath and ilioinguinal nerve block without local anaesthesia
Rectus sheath and ilioinguinal nerve block with local anaesthesia
Eligibility Criteria
You may qualify if:
- The donors reviewed by the transplant committee and deemed suitable for nephrectomy.
- Laparoscopic hand assisted donor nephrectomy operation is planned.
You may not qualify if:
- Allergy to any of the drugs to be used in treatment
- Patients using chronic narcotics or narcotic receptor agonists
- Patients with psychiatric disorders
- Patients with chronic organ failure
- Patients without end organ damage
- The patients who did not give consent
- Foreign national patients
- Patients with American Society of Anaesthesiologists (ASA) physical status classification score III and above
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Koç Universitylead
Study Sites (1)
Koç University Hospital
Istanbul, Zeytinburnu, Turkey (Türkiye)
Related Publications (2)
Ozkalayci O, Karakaya MA, Yenigun Y, Cetin S, Darcin K, Akyollu B, Arpali E, Kocak B, Gurkan Y. Effects of erector spinae plane block on opioid consumption in patients undergoing hand-assisted laparoscopic donor nephrectomy: a randomized controlled trial. Minerva Anestesiol. 2024 Mar;90(3):154-161. doi: 10.23736/S0375-9393.23.17706-6. Epub 2024 Feb 2.
PMID: 38305014RESULTGunaydin B, Ucar T, Arpali E, Akyollu B, Akinci S, Karatas C, Oztorun K, Kocak B. Hand-assisted laparoscopic donor nephrectomy: 1864 cases in 15 years of experience. Turk J Med Sci. 2022 Aug;52(4):1322-1328. doi: 10.55730/1300-0144.5438. Epub 2022 Aug 10.
PMID: 36326419RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yasemin Sincer, MD
Koç University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- The patient will be blind whether they receive local anaesthesia or physiological saline as the nerve block ingredient. The care providers will be blind to the solution when they are performing the regional anaesthesia. The care providers will be blind when they are monitoring the patient after surgery.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2025
First Posted
April 23, 2025
Study Start
March 30, 2025
Primary Completion
July 28, 2025
Study Completion
July 28, 2025
Last Updated
August 28, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share